9.8
Aumento da biodisponibilidade: determinação e abordagens conceituais para superar problemas de biodisponibilidade
A biodisponibilidade é um conceito farmacológico fundamental que mede a extensão e a velocidade com que um ingrediente ativo ou entidade terapêutica a…
A biodisponibilidade refere-se à quantidade de medicamento inalterado que atinge a circulação sistêmica.
Os medicamentos são categorizados no sistema de classificação biofarmacêutica em quatro classes com base em sua solubilidade e permeabilidade.
A solubilidade do medicamento pode ser determinada pelo perfil de solubilidade do pH e pelos métodos de agitação-frasco ou titulação.
Enquanto isso, os métodos de determinação de permeabilidade incluem estudos farmacocinéticos de balanço de massa, estudos de perfusão intestinal in vivo e experimentos de permeação com tecido intestinal ou monocamadas de células epiteliais.
Alguns fármacos com baixa solubilidade e permeabilidade apresentam baixa biodisponibilidade, que pode ser superada por abordagens farmacêuticas, farmacocinéticas e biológicas.
A abordagem farmacêutica envolve a modificação da formulação, processo de fabricação ou propriedades físico-químicas sem alterar a estrutura química do medicamento.
A abordagem farmacocinética modifica a estrutura química do medicamento por meio de projetos de pró-fármacos ou desenvolvimento de novas entidades químicas.
A abordagem biológica envolve a mudança da via de administração do medicamento, como a mudança da via oral para a parenteral.
View the full transcript and gain access to JoVE Core videos
Q1: What does bioavailability measure in pharmacology?
Bioavailability measures the amount of unchanged drug reaching the systemic circulation after administration. It reflects both the extent and rate at which an active drug ingredient enters the bloodstream, remaining chemically unchanged. This metric is critical for determining a drug's efficacy and safety profile in patients.
Q2: How does the Biopharmaceutics Classification System categorize drugs?
The Biopharmaceutics Classification System categorizes drugs into four classes based on their solubility and permeability characteristics. This classification system aids in understanding drug absorption characteristics and guiding formulation strategies. Drugs with low solubility and permeability often face challenges with poor bioavailability that require targeted enhancement approaches.
Q3: What methods are used to determine drug solubility?
Drug solubility is determined using pH-solubility profiling, which examines how solubility changes with pH, and shake-flask or titration methods, which determine solubility in different solvents or at various pH levels. These techniques help predict a drug's absorption characteristics and guide formulation development strategies for improving bioavailability.
Q4: What are the main approaches to overcome poor drug bioavailability?
Three primary approaches address poor bioavailability: the pharmaceutical approach modifies formulation, manufacturing, or physicochemical properties without changing chemical structure; the pharmacokinetic approach modifies the drug's chemical structure through prodrug designs or new chemical entities; and the biological approach changes the route of administration, such as switching from oral to parenteral routes.
Q5: How is drug permeability evaluated in bioavailability studies?
Permeability is evaluated through mass-balance pharmacokinetic studies, in vivo intestinal perfusion studies, and permeation experiments using intestinal tissue or epithelial cell monolayers. These methods help predict a drug's absorption and bioavailability by assessing how effectively the drug crosses biological membranes in the gastrointestinal tract.
Q6: What is the pharmaceutical approach to enhancing bioavailability?
The pharmaceutical approach alters the drug's formulation, manufacturing process, or physicochemical properties without changing the molecular structure. This strategy can involve using solubilizers, reducing particle size, or forming amorphous solids to improve drug dissolution and absorption, thereby enhancing bioavailability without modifying the active ingredient itself.
Q7: How does the biological approach improve drug bioavailability?
The biological approach explores alternative routes of administration to bypass limitations associated with oral bioavailability. Switching from an oral to a parenteral route allows the drug to be administered directly into the systemic circulation, avoiding the gastrointestinal tract and its absorption barriers, thereby improving overall drug bioavailability and therapeutic effectiveness.